This document introduces the knowledge of the detection and delaying of chronic kidney disease, including GFR, ACR, the diagnosis and classification of CKD, as well as treatment methods.
This document serves as a guide for primary care physicians (PCPs) on the detection and management of Chronic Kidney Disease (CKD). It outlines evidence-based strategies for screening, utilizing tools such as GFR and ACR, and classifying CKD based on GFR and albuminuria categories to guide treatment approaches.
The guide details clinical evaluation methods, including blood pressure control, glycemic management, and the avoidance of nephrotoxic agents like NSAIDs. It also provides specific targets for blood pressure and albuminuria reduction to delay disease progression and improve patient outcomes, alongside recommendations for patient education and counseling.
Albuminuria categories include A1 (normal to mildly increased), A2 (moderately increased), and A3 (severely increased).
The target blood pressure is ≤130/80 mm Hg for patients with ACR 30-300 mg/g.
Limit sodium intake to <90 mmol (2 gm sodium) per day.
The target HbA1c is ~7.0%.